R. Xhonneux

2.1k total citations · 1 hit paper
50 papers, 1.7k citations indexed

About

R. Xhonneux is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, R. Xhonneux has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in R. Xhonneux's work include Cardiac electrophysiology and arrhythmias (10 papers), Cardiac Ischemia and Reperfusion (10 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). R. Xhonneux is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Cardiac Ischemia and Reperfusion (10 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). R. Xhonneux collaborates with scholars based in Belgium, Netherlands and Germany. R. Xhonneux's co-authors include A. Van de Water, P A Janssen, Jan M. Van Nueten, P M Vanhoutte, Johan van Beek, R. S. Reneman, T J Verbeuren, Wolfgang Schäper, Jef Verheyen and Paul A. J. Janssen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

R. Xhonneux

48 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

1981 433 citations Jan M. Van Nueten, P A Janssen et al. Journal of Pharmacology and Experimental Therapeutics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
R. Xhonneux	817	593	321	287	213	50	1.7k
Koroku Hashimoto	754 0.9×	515 0.9×	291 0.9×	241 0.8×	105 0.5×	152	1.6k
Adawia A. Alousi	1.1k 1.4×	703 1.2×	314 1.0×	188 0.7×	132 0.6×	30	2.0k
Kathleen A. Kane	1.2k 1.5×	904 1.5×	440 1.4×	281 1.0×	463 2.2×	120	2.2k
Frank C. Messineo	803 1.0×	607 1.0×	183 0.6×	125 0.4×	163 0.8×	46	1.6k
Winifred G. Nayler	1.4k 1.7×	1.1k 1.8×	544 1.7×	437 1.5×	528 2.5×	130	2.6k
A. Edlund	540 0.7×	350 0.6×	612 1.9×	145 0.5×	163 0.8×	53	1.8k
Robert E. Beamish	1.4k 1.7×	932 1.6×	447 1.4×	154 0.5×	512 2.4×	71	2.6k
P Zera	1.0k 1.2×	651 1.1×	510 1.6×	164 0.6×	139 0.7×	6	1.6k
S. Holzmann	525 0.6×	464 0.8×	814 2.5×	195 0.7×	357 1.7×	47	1.6k
M. Koltai	435 0.5×	402 0.7×	313 1.0×	151 0.5×	397 1.9×	92	1.6k

Countries citing papers authored by R. Xhonneux

Since Specialization

Citations

This map shows the geographic impact of R. Xhonneux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Xhonneux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Xhonneux more than expected).

Fields of papers citing papers by R. Xhonneux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Xhonneux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Xhonneux. The network helps show where R. Xhonneux may publish in the future.

Co-authorship network of co-authors of R. Xhonneux

This figure shows the co-authorship network connecting the top 25 collaborators of R. Xhonneux. A scholar is included among the top collaborators of R. Xhonneux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Xhonneux. R. Xhonneux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Water, A. Van de, R. Xhonneux, Fred De Clerck, & James T. Willerson. (1991). Heparin knhances the synergism between platelet TXA2synthase inhibitioh/receptor blockade (ridogrel) and tissue plasminogen activator in lysing canine coronary thrombi. Journal of the American College of Cardiology. 17(2). A52–A52. 1 indexed citations

Janssens, W. J., R. Xhonneux, & Paul A. J. Janssen. (1991). Animal Pharmacology of Nebivolol. Clinical Drug Investigation. 3(S1). 13–24. 18 indexed citations

Vandeplassche, G, A. Van de Water, R. Xhonneux, et al.. (1991). Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.. Circulation Research. 69(2). 313–324. 10 indexed citations

Xhonneux, R., Luc Wouters, Robert S. Reneman, & Paul A. J. Janssen. (1990). The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer. European Journal of Pharmacology. 181(3). 261–265. 29 indexed citations

Janssens, W. J., A. Van de Water, R. Xhonneux, et al.. (1989). Nebivolol is devoid of intrinsic sympathomimetic activity. European Journal of Pharmacology. 159(1). 89–95. 43 indexed citations

Water, A. Van de, Jef Verheyen, R. Xhonneux, & R. S. Reneman. (1989). An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. Journal of Pharmacological Methods. 22(3). 207–217. 263 indexed citations

Water, A. Van de, R. Xhonneux, Robert S. Reneman, & P A Janssen. (1988). Cardiovascular effects of dl-nebivolol and its enantiomers — a comparison with those of atenolol. European Journal of Pharmacology. 156(1). 95–103. 49 indexed citations

Water, A. Van de, Wim Janssens, R. Xhonneux, et al.. (1988). Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist. Journal of Cardiovascular Pharmacology. 11(5). 552–563. 167 indexed citations

Borgers, Μ., et al.. (1987). Changes in ultrastructure and Ca2+ distribution in the isolated working rabbit heart after ischemia. A time-related study.. PubMed. 126(1). 92–102. 49 indexed citations

10.

Flameng, Willem, et al.. (1985). Prevention of the “no reflow” phenomenon in the canine heart by mioflazine. Basic Research in Cardiology. 80(1). 27–36. 5 indexed citations

11.

Vandeplassche, G, et al.. (1984). Beneficial effect of mioflazine in limiting myocardial infarct size in the anesthetized dog.. PubMed. 44(1). 167–70. 2 indexed citations

12.

Xhonneux, R., et al.. (1981). Lorcainide (R 15 889), a first review.. PubMed. 36(3). 207–34. 18 indexed citations

13.

Nueten, Jan M. Van, R. Xhonneux, P M Vanhoutte, & P A Janssen. (1981). Vascular activity of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist.. PubMed. 250(2). 328–9. 6 indexed citations

14.

Nueten, Jan M. Van, R. Xhonneux, & P A Janssen. (1978). Preliminary data on antiserotonin effects of oxatomide, a novel anti-allergic compound.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 232(2). 217–20. 12 indexed citations

15.

Xhonneux, R., et al.. (1978). Effect of lorcainide, a new antiarrhythmic compound, on the changes in heart rhythm induced by intravenous injection of adenosine-5'-diphosphate in rats.. PubMed. 231(2). 222–31. 7 indexed citations

16.

Carmeliet, Edward, et al.. (1976). Electrophysiological effects of droperidol in different cardiac tissues. Naunyn-Schmiedeberg s Archives of Pharmacology. 293(1). 57–66. 24 indexed citations

17.

Carmeliet, Edward & R. Xhonneux. (1971). Influence of lidoflazine on cardiac transmembrane potentials and experimental arrhythmias. Naunyn-Schmiedeberg s Archives of Pharmacology. 268(2). 210–228. 14 indexed citations

18.

Schäper, Wolfgang, et al.. (1970). The cardiovascular pharmacology of lidoflazine.. PubMed. 50(9). 635–8. 2 indexed citations

19.

Schäper, Wolfgang, Anton H. M. Jageneau, & R. Xhonneux. (1967). The Development of Collateral Circulation in the Pig and Dog Heart. Cardiology. 51(6). 321–335. 95 indexed citations

20.

Schäper, Wolfgang, R. Xhonneux, Anton H. M. Jageneau, & Paul A. J. Janssen. (1966). THE CARDIOVASCULAR PHARMACOLOGY OF LIDOFLAZINE, A LONG-ACTING CORONARY VASODILATOR. Journal of Pharmacology and Experimental Therapeutics. 152(2). 265–274. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact